SHIP1 and its role for innate immune regulation—Novel targets for immunotherapy
Abstract: Phosphoinositide‐3‐kinase/AKT (PI3K/AKT) signaling plays key roles in the regulation of cellular activity in both health and disease. In immune cells, this PI3K/AKT pathway is critically regulated by the phosphoinositide phosphatase SHIP1, which has been reported to modulate the function of most immune subsets. In this review, we summarize our current knowledge of SHIP1 with a focus on innate immune cells, where we reflect on the most pertinent aspects described in the current literature. We also present several small‐molecule agonists and antagonists of SHIP1 developed over the last two decades, which have led to improved outcomes in several preclinical models of disease. We outline these promising findings and put them in relation to human diseases with unmet medical needs, where we discuss the most attractive targets for immune therapies based on SHIP1 modulation.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
SHIP1 and its role for innate immune regulation—Novel targets for immunotherapy ; day:27 ; month:10 ; year:2023 ; extent:18
European journal of immunology ; (27.10.2023) (gesamt 18)
- Urheber
-
Yeoh, Wen Jie
Krebs, Philippe
- DOI
-
10.1002/eji.202350446
- URN
-
urn:nbn:de:101:1-2023102715332743407256
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yeoh, Wen Jie
- Krebs, Philippe
Ähnliche Objekte (12)
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Innate immune training of granulopoiesis : a novel target in cancer immunotherapy
Exploiting innate immunity for cancer immunotherapy
Identification of novel immune checkpoints as targets for cancer immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy
S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Innate immune training of granulopoiesis : a novel target in cancer immunotherapy
Exploiting innate immunity for cancer immunotherapy
Identification of novel immune checkpoints as targets for cancer immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy
S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Innate Immune Activation with Multifunctional Nanoparticles for Cancer Immunotherapy
Innate immune training of granulopoiesis : a novel target in cancer immunotherapy
Exploiting innate immunity for cancer immunotherapy
Identification of novel immune checkpoints as targets for cancer immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy
S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy